Loading clinical trials...

A Study of Econazole Foam 1% in Athlete's Foot | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT00768599

A Study of Econazole Foam 1% in Athlete's Foot

This is a 6-week clinical study (4 weeks of treatment, once per day, plus a 2-week follow-up period) of a topical foam to treat athlete's foot. The active ingredient in the foam -- econazole nitrate 1...

Lead sponsor: AmDerma•6 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

RECRUITINGPhase 2

Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study

NCT07245667 · Tinea Pedis

COMPLETED

Spread of Dermatophytes Among Families

NCT00233493 · Onychomycosis, Tinea Pedis

COMPLETEDPhase 3

Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis

NCT03129321 · Tinea Pedis

COMPLETEDPhase 2

A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis

NCT03897257 · Tinea Pedis

COMPLETEDNA

Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea Pedis

NCT00804193 · Tinea Pedis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 9, 2013Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment135

Start dateMar 2008

Last updatedJan 9, 2013

Condition

Tinea Pedis Athlete's Foot

Locations shown

Stacy Smith, MD

San Diego, California

Daniel Stewart, DO

Clinton Township, Michigan

Steven Kempers, MD

Fridley, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 9, 2013Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions